Hidetoshi Hayashi

49PUBLICATIONS
226CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCellular immunologyRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (49)

|Jul 07, 2026
Intratumoral heterogeneity of intermediate CLDN18.2 expression in gastric cancer.

|May 13, 2026
Nivolumab plus chemoradiotherapy followed by nivolumab with or without ipilimumab for untreated locally advanced stage III NSCLC: a randomized phase 3 trial.

|Mar 11, 2026
Constitutive EGFR Activation Induced by PTPRR Downregulation Confers Resistance to KRAS Inhibitors.

Hiroaki Kanemura, Toshiyuki Takehara, Osamu Maenishi

|Feb 02, 2026
Analysis of Peripheral T Cell Profiling and Plasma Proteomics in Advanced NSCLC Patients Treated With Atezolizumab.

Atsuto Mouri, Hiroshi Kagamu, Koji Tamada

|Nov 13, 2025
C-Reactive Protein in Immune Checkpoint Inhibitor-Associated Colitis: A Scoping Review of Evidence and Knowledge Gaps.

Ryuichi Ohta, Yoshinori Ryu, Kaoru Tanaka

|Nov 13, 2025
Zongertinib, a Novel HER2 Tyrosine Kinase Inhibitor, Maintains an Anticancer Activity for Trastuzumab Deruxtecan-Resistant Cancers Harboring HER2-Overexpression.

Takashi Kurosaki, Shinichiro Suzuki, Kimio Yonesaka

Pageof 9

Frequent Collaborators

9 joint publications

Kazuto Nishio

7 joint publications

Hisato Kawakami

7 joint publications

Kazuhiko Nakagawa

6 joint publications

Shinichiro Suzuki